Locally Advanced Basal Cell Carcinoma: Two Severe Case Presentations and Review.

Locally Advanced Basal Cell Carcinoma: Two Severe Case Presentations and Review. J Drugs Dermatol. 2018 Mar 01;17(3):358-362 Authors: Brown L, David J, Skopit S Abstract Basal cell carcinoma (BCC) is a common skin malignancy comprising 80% of non-melanoma skin cancers.1 Over 2.8 million cases are estimated to be diagnosed in the United States alone each year. Advanced BCCs are comprised of BCCs that have metastasized to local or distant lymph nodes or organs, or locally invasive BCCs that are extensive and infiltrate vital structures such as eyes, nose, or brain. Advanced BCC tumors represent roughly 1-10% of BCCs today. Two severe case presentations and treatment options will be discussed in this case report series and review. <p><em>J Drugs Dermatol. 2018;17(3):358-362.</em></p>. PMID: 29537455 [PubMed - in process]
Source: Journal of Drugs in Dermatology - Category: Dermatology Tags: J Drugs Dermatol Source Type: research